A COMPREHENSIVE OVERVIEW ON MANAGEMENT OF FUNGAL DISEASE BY VACCINES, DRAWBACKS, AND CHALLENGES

Memona Sajid; Saba Sana; Fatima Basharat; Ali Ahmad; Asif Shaheen; Aqsa Ilyas; Muhammad Athar Arif; Khadija Atif

doi:10.25271/sjuoz.2026.14.3.1843

Memona Sajid⁽¹⁾ , Saba Sana⁽²⁾ , Fatima Basharat⁽³⁾ , Ali Ahmad⁽⁴⁾ , Asif Shaheen⁽⁵⁾ , Aqsa Ilyas⁽⁶⁾ , Muhammad Athar Arif⁽⁷⁾ , Khadija Atif⁽⁸⁾

(1) Department of Microbiology, Dr. Ikram ul Haq Institute of Industrial Biotechnology, Government College University, Lahore ,

(2) Department of Microbiology, Dr. Ikram ul Haq Institute of Industrial Biotechnology, Government College University Lahore ,

(3) Department of Microbiology, Dr. Ikram ul Haq Institute of Industrial Biotechnology, Government College University, Lahore ,

(4) Department of Microbiology, KBCMA College of Veterinary and Animal Sciences, Narowal ,

(5) Department of Microbiology, Dr. Ikram ul Haq Institute of Industrial Biotechnology, Government College University, Lahore ,

(6) Department of Biological Sciences, University of Veterinary and Animal Sciences, Lahore ,

(7) Department of Microbiology, Dr. Ikram ul Haq Institute of Industrial Biotechnology, Government College University, Lahore ,

(8) Department of Microbiology, Dr. Ikram ul Haq Institute of Industrial Biotechnology, Government College University, Lahore,

https://doi.org/10.25271/sjuoz.2026.14.3.1843

Issue
Vol. 14 No. 3 (2026): July-September issue

Submitted
November 25, 2025

Accepted
March 24, 2026

Published
July 2, 2026

Keywords:

Antifungal Agents, Antifungal Resistance, Fungal Diseases, Fungal Pathogenesis, Medical Mycology, Mycoses

No galleys available

Abstract

Infections caused by fungi are a large and varied category of diseases that impact all living things on Earth. Underscoring their worldwide epidemiological effect, this review focusses on the categorization, pathogenic processes, and clinical symptoms of superficial and systemic mycoses. Morphological traits, virulence factors, and environmental adaptations that allow survival and infection are examined in relation to several fungal taxa. New opportunistic fungi and the rise of resistant strains are other topics of discussion. Antifungals and fungal vaccine and diagnostic methods are in the review. In order to better diagnose, prevent, and manage mycotic infections, it is essential to understand the biology and pathogenicity of fungi. This document also summarizes current research in medical mycology and suggests areas for future study to control fungal illnesses and to reduce their economic and health impacts.

Full text article

Generated from XML file

References

Abza, F., & Babeta, F. A. (2023). Cutaneous chromoblastomycosis (Version 1). Research Square Platform LLC. DOI:https://doi.org/10.21203/rs.3.rs-3659659/v1

Ahmed, A. O. A., & de Hoog, G. S. (2011). Fungi causing eumycotic mycetoma. In J. Versalovic, K. C. Carroll, G. Funke, J. H. Jorgensen, M. L. Landry, & D. W. Warnock (Eds.), Manual of Clinical Microbiology (pp. 1–15). DOI:https://doi.org/10.1128/9781555816728.ch123

Alhaddad, A. A. (2022). Mycotoxins... silent death. IntechOpen. DOI:https://doi.org/10.5772/intechopen.104382

Ali, T. (2022). Mycotoxins and mycotoxicosis. Pakistan Journal of Science, 72(4). DOI:https://doi.org/10.57041/pjs.v72i4.267

Al-Janabi, S. A. H., & Ali, R. (2020). Asthma and aspergillosis: Which one causes another. Biomedical and Biotechnology Research Journal (BBRJ), 4(1), 16. DOI:https://doi.org/10.4103/bbrj.bbrj_149_19

Barros, M. B. D. L., De Almeida Paes, R., & Schubach, A. O. (2011). Sporothrix schenckii and sporotrichosis. Clinical Microbiology Reviews, 24(4), 633–654. DOI:https://doi.org/10.1128/cmr.00007-11

Baveja, P., Paliwal, G., Rajkamal, T., & Walia, G. K. (2021). Chromoblastomycosis. Medical Journal of Dr. D.Y. Patil Vidyapeeth, 14(6), 703–705. DOI:https://doi.org/10.4103/mjdrdypu.mjdrdypu_570_20

Benedict, K., Roy, M., Chiller, T., & Davis, J. P. (2012). Epidemiologic and ecologic features of blastomycosis: A review. Current Fungal Infection Reports, 6(4), 327–335. DOI:https://doi.org/10.1007/s12281-012-0110-1

Bongomin, F., Gago, S., Oladele, R. O., & Denning, D. W. (2017). Global and multi-national prevalence of fungal diseases—Estimate precision. Journal of Fungi, 3(4), 57. DOI:https://doi.org/10.3390/jof3040057

Cai, H., Gu, J., Wang, Y., Guo, D. H., & Zhang, H. (2022). Genomic data mining reveals abundant uncharacterized transporters in Coccidioides immitis and Coccidioides posadasii. Journal of Fungi, 8(10), 1064. DOI:https://doi.org/10.3390/jof8101064

Campuzano, A., Pentakota, K. D., Liao, Y.-R., Zhang, H., Wiederhold, N. P., Ostroff, G. R., & Hung, C.-Y. (2024). A recombinant multivalent vaccine (rCpa1) induces protection for C57BL/6 and HLA transgenic mice against pulmonary infection with both species of Coccidioides. Vaccines, 12(1), 67. DOI:https://doi.org/10.3390/vaccines12010067

Casadevall, A. (2022). Immunity to invasive fungal diseases. Annual Review of Immunology, 40(1), 121–141. DOI:https://doi.org/10.1146/annurev-immunol-101220-034306

Casadevall, A., & Pirofski, L. A. (2002). What is a pathogen? Annals of Medicine, 34(1), 2–4. DOI:https://doi.org/10.1080/078538902317338580

Cassone, A. (2008). Fungal vaccines: Real progress from real challenges. The Lancet Infectious Diseases, 8(2), 114–124. DOI:https://doi.org/10.1016/S1473-3099(08)70016-1

Cunha, C. B., Koestenblatt, E. K., & Weinberg, J. M. (2021). Superficial fungal infection of skin and nails. In C. B. Cunha (Ed.), Schlossberg’s Clinical Infectious Disease

(3rd ed., online ed., pp. 1–15). Oxford Academic. DOI:https://doi.org/10.1093/med/9780190888367.003.0026

De Leo, F., De Domenico, E., Alaimo, C., Rappazzo, A. C., De Carlo, G., Lo Giudice, A., Urzì, C., & Graziano, M. (2018). Occurrence of the black yeast Hortaea werneckii in the Mediterranean Sea. Extremophiles, 23(1), 9–17. DOI:https://doi.org/10.1007/s00792- 018-1056-1

Denning, D. W. (2024). Global incidence and mortality of severe fungal disease. The Lancet Infectious Diseases, 24(7), 428–438. DOI:https://doi.org/10.1016/S1473-3099(23)00692-8

Fathur Rachman, A. (2020). Case report: Subcutaneous fungal cyst resembling as benign tumor. International Journal of Infectious Diseases, 101, 392. DOI:https://doi.org/10.1016/j.ijid.2020.09.1026

Fernandes, C. M., Normile, T. G., Fabri, J. H. T. M., Brauer, V. S., Araújo, G. R. de S., Frases, S., Nimrichter, L., Malavazi, I., & Del Poeta, M. (2022). Vaccination with live or heat-killed Aspergillus fumigatusΔsglA conidia fully protects immunocompromised mice from invasive aspergillosis. mBio, 13(5), e02328-22. DOI:https://doi.org/10.1128/mBio.02328-22

Freitas, D. F. S., Francesconi, F., De Macedo, P. M., & Gutierrez- Galhardo, M. C. (2020). Subcutaneous fungal infections. In Reference Module in Life Sciences (pp. 695–706). Elsevier. DOI:https://doi.org/10.1016/b978-0-12-809633-8.21014-5

Garcia-Vidal, C., Peghin, M., Cervera, C., Gudiol, C., Ruiz- Camps, I., Moreno, A., Royo-Cebrecos, C., Roselló, E., Puig de la Bellacasa, J., Ayats, J., & Carratalà, J. (2015). Causes of death in a contemporary cohort of patients with invasive aspergillosis. PLOS ONE, 10(3), e0120370. DOI:https://doi.org/10.1371/journal.pone.0120370

Garg, A., Sharma, G. S., Goyal, A. K., Ghosh, G., Si, S. C., & Rath, G. (2020). Recent advances in topical carriers of anti-fungal agents. Heliyon, 6(8), e04663. DOI:https://doi.org/10.1016/j.heliyon.2020.e04663

Gupta, A. K., Stec, N., Summerbell, R. C., Shear, N. H., Piguet, V., Tosti, A., & Piraccini, B. M. (2020). Onychomycosis: A review. Journal of the European Academy of Dermatology and Venereology, 34(7), 1493–1506. DOI:https://doi.org/10.1111/jdv.16394

Hay, R. J. (2024). Fungal infections. In J. Barker, C. Griffiths, T. Bleiker, R. Simpson, & W. Hussain (Eds.), Rook’s Textbook of Dermatology. DOI: https://doi.org/10.1002/9781119709268.rook032

Hayati, T., Korkorian, N., Pashotan, N., Hashemi Fesharaki, H. S., & Kiani, M. (2024). An overview of recombinant vaccines against viral, fungal, bacterial and parasitic diseases. International Journal of New Findings in Health and Educational Sciences, 2(4), 103–122. DOI:https://doi.org/10.63053/ijhes.104

Inácio, M. M., Ribeiro-Dias, F., Moreira, A. L. E., Soares, C. M. D. A., Borges, C. L., Cruz-Leite, V. R. M., Mattos, K., Silva, L. O. S., Venturini, J., Ruiz, O. H., & Weber, S. S. (2023). Fungal vaccine development: State of the art and perspectives using immunoinformatics. Journal of Fungi, 9(6), 633. DOI:https://doi.org/10.3390/jof9060633

Jain, S. K., Singh, A., Kushwaha, R. K., Mohta, A., & Nyati, A. (2019). A case of scalp white piedra caused by Trichosporon ovoides. International Journal of Trichology, 11(3), 134. DOI:https://doi.org/10.4103/ijt.ijt_19_19

Kelarestaghi, A., Hashemi, S. J., Rafat, Z., Kelarestaghi, H., Moqaddam, Z. R., Maboudi, A., & Khodavaisy, S. (2022). The first report of tinea nigra from Iran. New Microbes and New Infections, 49–50(6), 101032. DOI:https://doi.org/10.1016/j.nmni.2022.101032

Kobayashi, G. S. (2001). Mycoses. In eLS (Ed.). DOI:https://doi.org/10.1038/npg.els.0000371

Kosal, E. (2023). Introductory biology: Ecology, evolution, and biodiversity. North Carolina State University.

La Hoz, R. M., & Baddley, J. W. (2012). Subcutaneous fungal infections. Current Infectious Disease Reports, 14(5), 530–539. DOI:https://doi.org/10.1007/s11908-012-0275-3

Liu, M., Clemons, K. V., Bigos, M., Medovarska, I., Brummer, E., & Stevens, D. A. (2011). Immune responses induced by heat-killed Saccharomyces cerevisiae: A vaccine against fungal infection. Vaccine, 29(9), 1745–1753. DOI:https://doi.org/10.1016/j.vaccine.2010.12.119

Loh, J. T., & Lam, K.-P. (2023). Fungal infections: Immune defense, immunotherapies and vaccines. Advanced Drug Delivery Reviews, 196, 114775. DOI:https://doi.org/10.1016/j.addr.2023.114775

Mahajan, V. K. (2014). Sporotrichosis: An overview and therapeutic options. Dermatology Research and Practice, 2014(6), 1–13.

DOI:https://doi.org/10.1155/2014/272376

Mahajan, V. K. (2021). Sporotrichosis: A brief review. Cosmoderma, 1, 10. DOI:https://doi.org/10.25259/csdm_4_2021

Merkhofer, R. M., Pepperell, C. S., Wuethrich, M., Xiong, D., Fites, J. S., Klein, B. S., O’Neill, M. B., Shockey, A. C., Dobson, H., & Hernandez-Santos, N. (2019). Investigation of genetic susceptibility to blastomycosis reveals interleukin-6 as a potential susceptibility locus. MBio, 10(3). DOI:https://doi.org/10.1128/mbio.01224-19

Oliveira, L. V. N., Wang, R., Specht, C. A., Levitz, S. M., & Nosanchuk, J. D. (2021). Vaccines for human fungal diseases: Close but still a long way to go. npj Vaccines, 6(1), 33. DOI:https://doi.org/10.1038/s41541-021-00294-8

Proia, L. A. (2010). Treatment of blastomycosis. Current Fungal Infection Reports, 4(1), 23–29. DOI:https://doi.org/10.1007/s12281- 010-0003-0

Pury, S., Caliva Agüero, S., Sasia, L., Álvarez, M. S., & Disandro, D. (2023). Disseminated histoplasmosis in an immunocompetent pediatric patient. Archivos Argentinos de Pediatria, 121(3). DOI:https://doi.org/10.5546/aap.2022-02715.eng

Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017). Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis. The Lancet Infectious Diseases, 17(8), 873–881. DOI:https://doi.org/10.1016/S1473- 3099(17)30243-8

Rayens, E., Rabacal, W., Willems, H. M. E., Oworae, K. O., Peters, B. M., & Norris, K. A. (2022). Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis. PNAS Nexus, 1(5), pgac248. DOI:https://doi.org/10.1093/pnasnexus/pgac248

Ribeiro, A. M., Felipe, M. S. S., Bocca, A. L., & Amaral, A. C. (2017). DNAhsp65 vaccine as therapy against paracoccidioidomycosis. In Methods in molecular biology (Vol. 1625, pp. 85–96). Humana Press. DOI:https://doi.org/10.1007/978-1-4939-7104-6_7

Rimet Borges, J., Ianhez, M., Medeiros Eda, Y. V., & Garcia- Zapata, M. T. A. (2022). Diagnosis of chromoblastomycosis: An historical review. Revista de Patologia Tropical/Journal of Tropical Pathology, 51(2), 97–115. DOI:https://doi.org/10.5216/rpt.v51i2.71026

Rivera, A., Lodge, J., & Xue, C. (2022). Harnessing the immune response to fungal pathogens for vaccine development. Annual Review of Microbiology, 76, 703–726. DOI:https://doi.org/10.1146/annurev-micro-041020-111511

Sharma, B., & Nonzom, S. (2021). Superficial mycoses, a matter of concern: Global and Indian scenario: An updated analysis. Mycoses, 64(8), 890–908. DOI:https://doi.org/10.1111/myc.13264

Sharma, C., & Kadosh, D. (2023). Perspective on the origin, resistance, and spread of the emerging human fungal pathogen Candida auris. PLoS Pathogens, 19(3), e1011190. DOI:https://doi.org/10.1371/journal.ppat.1011190

Singh, G. (2024). Mortality outcomes associated with invasive aspergillosis. Era’s Journal of Medical Research, 11(2), 160–167.

DOI:https://doi.org/10.24041/ejmr2024.28

Stempinski, P. R., Ramos Irizarry, P., Mcconnell, S. A., Liporagi Lopes, L. C., Rodrigues Dos Santos Júnior, S., Wear, M. P., & Casadevall, A. (2025). A Cryptococcus neoformans polysaccharide conjugate vaccine made with filtered polysaccharide elicits protective immunity in mice. Fungal Biology, 129(2), 101544. DOI:https://doi.org/10.1016/j.funbio.2025.101544

Tang, Q., Zhou, Y., Chen, J., Chen, Y., & Xiong, X. (2023). Dynamic observation of atypical sporotrichosis before and after itraconazole treatment by dermoscopy. Clinical, Cosmetic and Investigational Dermatology, 16, 339–343. DOI:https://doi.org/10.2147/ccid.s400302

Tso, G. H. W., Reales-Calderon, J. A., & Pavelka, N. (2018). The elusive anti-Candida vaccine: Lessons from the past and opportunities for the future. Frontiers in Immunology, 9(Suppl 4). DOI:https://doi.org/10.3389/fimmu.2018.00897

Wang, Y., Wang, K., Masso-Silva, J. A., Rivera, A., & Xue, C. (2019). A heat-killed Cryptococcus mutant strain induces host protection against multiple invasive mycoses in a murine vaccine model. mBio, 10(6), e02145-19. DOI:https://doi.org/10.1128/mBio.02145-19

Woodring, T., Deepe, G. S., Levitz, S. M., Wuethrich, M., & Klein, B. S. (2022). These shall not grow mold: Soldiers of innate and adaptive immunity to fungi. Seminars in Immunology, 65, 101673. DOI:https://doi.org/10.1016/j.smim.2022.101673

Yeo, K. W., Kulasegarah, J., & Saniasiaya, J. (2023). Sporotrichosis in children: A forgotten entity. Journal of Health and Translational Medicine, 26(2), 204–207. DOI:https://doi.org/10.22452/jummec.vol26no2.29

Zaragoza, O., Rodrigues, M. L., De Jesus, M., Frases, S., Dadachova, E., & Casadevall, A. (2009). The capsule of the fungal pathogen Cryptococcus neoformans. Advances in Applied

Microbiology, 68, 133–216. DOI:https://doi.org/10.1016/S0065- 2164(09)01204-0

Authors

Memona Sajid

Saba Sana

saba.sana@gcu.edu.pk (Primary Contact)

Fatima Basharat

Ali Ahmad

Asif Shaheen

Aqsa Ilyas

Muhammad Athar Arif

Khadija Atif

Sajid, M., Sana, S., Basharat, F., Ahmad, A., Shaheen, A., Ilyas, A., Arif, M. A., & Atif, K. (2026). A COMPREHENSIVE OVERVIEW ON MANAGEMENT OF FUNGAL DISEASE BY VACCINES, DRAWBACKS, AND CHALLENGES. Science Journal of University of Zakho, 14(3), 454-462. https://doi.org/10.25271/sjuoz.2026.14.3.1843

Download Citation

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-SA 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work, with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online.

How to Cite